Article references (24 references )


  1. Leger P, Cambus JP, Boneu B, Boccalon H. Les cliniques d’anticoagulants. Sang Thromb Vaiss. 2003; 15(6): 288-90. Google Scholar

  2. Kamdem FD, Adoubi AK, Diby FK, Harding D, Ekra A. Utilisation des antithrombotiques en Afrique Subsaharienne: expérience de l’Institut de cardiologie d’Abidjan. Médecine d'Afrique Noire. 2007; 54(4): 209-214. Google Scholar

  3. Pautas E, Mitha N, Monti A, Boddaert J, Gouin-Thibault I. Gestion des accidents des anticoagulants aux urgences. URGENCES. 2011; 185-196. Google Scholar

  4. The World BANK. Perspective Monde, Espérance de vie au Burkina Faso. Accessed on 31 Jan 2014.

  5. INSD. Évolution de l’espérance de vie à la naissance, Tableau 03.01. Accessed on 04/02/2014.

  6. Pouyanne P, Haramburu F, Imbs JL, Bégaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. BMJ. 2000 Apr 15; 320(7241): 1036. PubMed | Google Scholar

  7. Benhamou Y, Le Cam-Duchez V, Schneller JM et al. Expérience d’un centre de suivi et de conseil des traitements anticoagulants oraux en médecine de ville: résultats à cinq ans. Rev Med Interne. 2009 Jul; 30(7): 567-72. PubMed | Google Scholar

  8. Pirmohamed M, James S, Meakin S, Green C et Coll. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004 Jul 3; 329(7456): 15-9. PubMed | Google Scholar

  9. Wester JP, De Valk HW, Nieuwenhuis HK, Brouwer CB, Van der Graaf Y et Coll. Risk factors for bleeding during treatment of acute venous thromboembolis. Thromb Haemost. 1996 Nov; 76(5): 682-8. PubMed | Google Scholar

  10. PNUD, Ministère de l’habitat et de l’urbanisme Burkina Faso. Stratégie de lutte contre la pauvreté urbaine. Accessed on 04 Feb 2014.

  11. Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case control study. Am J Med. 1997 Jul; 103(1): 11-7. PubMed | Google Scholar

  12. Casais P, Sánchez Luceros A, Meschengieser S, Fondevila C, Santarelli M, Lazzari M. Bleeding risk factors in chronic oral anticoagulation with acenocumarol. Am J Hematol. 2000 Apr; 63(4): 192-6. PubMed | Google Scholar

  13. Landefeld CS, Byeth RJ. Anticoagulant related bleeding: clinical, epidemiology, prediction and prevention. Am J Med. 1993 Sep; 95(3): 315-28. PubMed | Google Scholar

  14. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med. 1989 Aug; 87(2): 144-52. PubMed | Google Scholar

  15. Palareti G, Leali N, Coccheri S et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet. 1996 Aug 17; 348(9025): 423-8. PubMed | Google Scholar

  16. Ben Ameur Y, Chaabane O, Zairi I, Longo S, Battikh K, Slimane ML. Les accidents hémorragiques graves sous AVK: études descriptive et pronostic. Tunisie Médicale. 2009; 87(11): 763-9. PubMed | Google Scholar

  17. Serghini I, Aissaoui Y, Quamouss Y, Sedikki R, Taj N, Alaoui JS, Zoubir M, Boughanem M. Les accidents aux AVK: étude rétrospective à propos de 30 cas. Pan Afr Med J. 2012; 11: 24. PubMed | Google Scholar

  18. Boccalon H. La clinique des anticoagulants: un concept incontournable. Ann Cardiol Angeiol (Paris). 2006 Jan; 55(1): 22-6. PubMed | Google Scholar

  19. Fihn SD, Mc Donell M, Martin D et al. Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med. 1993 Apr 1; 118(7): 511-20. PubMed | Google Scholar

  20. Constans J, Sampoux F, Jarnier P et al. Complications hémorragiques des anti vitaminiques K: à propos de 75 patients hospitalisés. J Mal Vasc. 1999 Jun; 24(3): 202-7. PubMed | Google Scholar

  21. Siguret V, Esquirol C, Debray M, Gouin I, Andreux JP, Pautas E. Surdosage en antivitamine K dans une population de patients hospitalisés âgés de plus de 70 ans. Presse Med. 2003 Jun 14; 32(21): 972-7. PubMed | Google Scholar

  22. Lacroix P, Portefaix O, Boucher M. Conditions de survenue des accidents hémorragiques intracrâniens des AVK. Arch Mal Coeur Vaiss. 1994 Dec; 87(12): 1715-9. PubMed | Google Scholar

  23. Launbjerg J, Egeblad H, Heaf J et al. Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med. 1991 Apr; 229(4): 351-5. PubMed | Google Scholar

  24. Bounameaux H. Complications hémorragiques des anticoagulants en angiologie. J Mal Vasc. 1994; 19(2): 98-102. PubMed | Google Scholar